Free Republic

Investors who take an interest in Clover Health Investments, Corp. (NASDAQ:CLOV) should definitely note that the Independent Director, Chelsea Clinton, recently paid US$2.53 per share to buy US$253k worth of the stock. However, it only increased shareholding by a small percentage, and it wasn't a huge purchase by absolute value, either. View our latest analysis for Clover Health Investments Clover Health Investments Insider Transactions Over The Last Year The insider Chamath Palihapitiya made the biggest insider purchase in the last 12 months. That single transaction was for US$10.0m worth of shares at a price of US$5.75 each. So it's clear...

Clover Health under DOJ, SEC investigation Chelsea Clinton is a board director at a health insurance company that has been accused of defrauding investors. Clover Health has been slapped with numerous investor lawsuits that claim the company and its leadership failed to disclose that it was under investigation by the Department of Justice for allegedly offering illegal kickbacks to health care providers in exchange for patient referrals. Several of the lawsuits were consolidated in April into a class action case, which accused Clover Health and its CEO Vivek Garipalli of "employ[ing] devices, schemes, and artifices to defraud" investors. Clinton’s involvement...